Source: Annual Congress 2010 - Does cost-effectiveness go together with best quality of treatment? New drivers in medicine



Rating:

Share or cite this content

Citations should be made in the following way:
J. Jarrett, M. Mugford, R. Iles, E. Sims (Norwich, Cambridge, Cawston, United Kingdom). Is newborn screening for cystic fibrosis cost-effective?. Eur Respir J 2010; 36: Suppl. 54, 5180

Member's Comments

No comment yet.

Related content which might interest you: 1-PRO "Newborn screening for cystic fibrosis should be added to routine newborn screening programmes" Source: Annual Congress 2010 - Pro/Con debates: 1. To screen or not to screen for cystic fibrosis: is it still the question, 2. Specific immunotherapy for asthma Year: 2010 Newborn screening for cystic fibrosis improves lung function and growth at time of transfer to adult care Source: Annual Congress 2011 - Cystic fibrosis: detection and monitoring of early lung disease Year: 2011 Should the D1152H variant be included in cystic fibrosis newborn screening programmes? Source: Virtual Congress 2020 – Cystic fibrosis Year: 2020 Newborn screening and carrier screening for cystic fibrosis: alternative or complementary? Source: Eur Respir J 2014; 43: 20-23 Year: 2004 Treatment strategies for cystic fibrosis: what's in the pipeline? Source: Annual Congress 2010 - High-priority questions on airway infections in diseases seen in children and adults Year: 2010 A new paradigm for the management of children with cystic fibrosis at home: experiences from a Dutch cystic fibrosis clinic Source: Virtual Congress 2021 – New technologies for the management of children with respiratory diseases Year: 2021 The value of lung function monitoring by means of a home monitor in patients with cystic fibrosis Source: Annual Congress 2011 - Cystic fibrosis: New aspects of diagnosis, inflammation and detecting exacerbation Year: 2011 Managing cystic fibrosis in the neonatal period Source: Eur Respir Monogr 2021; 92: 259-272 Year: 2021 How useful is thoracic ultrasound in CF exacerbation? Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment Year: 2015 How useful is the lung ultrasound in cystic fibrosis? Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016 Early diagnosis from newborn screening maximises survival in severe cystic fibrosis Source: ERJ Open Res, 4 (2) 00109-2017; 10.1183/23120541.00109-2017 Year: 2018 Comparison of nanoduct versus macroduct sweat test for the diagnosis of cystic fibrosis in the newborn screening programme in Switzerland Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis Year: 2012 Newborn screening for cystic fibrosis: opportunities and remaining challenges Source: Eur Respir Monogr 2014; 64: 65-76 Year: 2014 Supressive antimicrobial therapy in chronic bronchial infection: the example of cystic fibrosis Source: Annual Congress 2011 - Chronic bronchial infection: more than a syndrome Year: 2011 Preventing cross-contamination in cystic fibrosis – is outpatient segregation effective? Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health Year: 2008 Does this patient have cystic fibrosis?  Source: International Congress 2017 – GR6 Paediatric Ground Round: an interactive session Year: 2017 Indicators of pulmonary exacerbation in adults with cystic fibrosis (CF) Source: Annual Congress 2011 - Cystic fibrosis: New aspects of diagnosis, inflammation and detecting exacerbation Year: 2011 The future for a child born with cystic fibrosis today Source: Breathe 2007; 4: 16-23 Year: 2007 The use of telehealth system in improving adherence to nebulised treatment in children with cystic fibrosis: Benefits and pitfalls Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014